Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$68.26 USD
-1.04 (-1.50%)
Updated May 17, 2024 03:59 PM ET
After-Market: $68.25 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/24/24 |
---|---|
Current Quarter | 1.10 |
EPS Last Quarter | 0.94 |
Last EPS Surprise | 9.30% |
ABR | 2.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.09 |
Next Year | 4.06 |
EPS (TTM) | 4.03 |
P/E (F1) | 16.96 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 861.68M | 868.19M | 3.53B | 3.66B |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 861.68M | 868.19M | 3.54B | 3.67B |
Low Estimate | 861.68M | 868.19M | 3.51B | 3.66B |
Year ago Sales | 820.20M | 832.16M | 3.37B | 3.53B |
Year over Year Growth Est. | 5.06% | 4.33% | 4.64% | 3.92% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.10 | 0.99 | 4.09 | 4.06 |
# of Estimates | 1 | 1 | 3 | 2 |
Most Recent Consensus | NA | NA | NA | 4.11 |
High Estimate | 1.10 | 0.99 | 4.26 | 4.11 |
Low Estimate | 1.10 | 0.99 | 3.90 | 4.01 |
Year ago EPS | 1.03 | 1.07 | 4.01 | 4.09 |
Year over Year Growth Est. | 6.80% | -7.48% | 2.00% | -0.65% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | 1.10 | 0.99 | 4.09 | 4.06 |
7 Days Ago | 1.10 | 0.99 | 4.09 | 4.06 |
30 Days Ago | 1.10 | 0.99 | 4.12 | 4.10 |
60 Days Ago | 1.10 | 0.99 | 4.12 | 4.11 |
90 Days Ago | 1.10 | 0.99 | 4.12 | 4.16 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.10 | 0.99 | 4.08 | 4.06 |
Zacks Consensus Estimate | 1.10 | 0.99 | 4.09 | 4.06 |
Earnings ESP | 0.00% | 0.00% | -0.16% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.94 | 0.99 | 1.07 | 1.03 | NA |
Estimate | 0.86 | 0.87 | 0.88 | 0.71 | NA |
Difference | 0.08 | 0.12 | 0.19 | 0.32 | 0.18 |
Surprise | 9.30% | 13.79% | 21.59% | 45.07% | 22.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more